AXIM Looks to Help Chemotherapy Effects via CBD Chewing Gum with Dronabinol

  • AXIM’s contract manufacturer will be developing the new gum.
  • Rather than using THC or CBD, the formula includes a synthetic version of THC called dronabinol.

One of the consistent reasons for the use of medical marijuana has been in conjunction with a cancer diagnosis or cancer treatment, like chemotherapy. Chemotherapy can make patients lose their appetite, often from the nausea associated with their medication. While medical marijuana may not be the easiest method of use for some patients, AXIM Biotechnologies is using the substance for a new product that targets exactly this audience – a chewing gum.

According to reports from Market Exclusive, the chewing gum is being developed with dronabinol, which is a synthetic version of THC. AXIM’s contract manufacturer Eurofins Amatsigroup in Belgium is taking over the manufacturing of the new product, which will go through clinical studies with AXIM as a remedy for chemotherapy-related symptoms. Some of the symptoms of chemotherapy include a weakened immune system, pain, nausea, vomiting, and diarrhea.

Chemotherapy is prescribed to nearly 650,000 cancer patients every year, according to data from the Center for Disease Control and Prevention, costing about $100,000 per patient every year.

AXIM already has made plans for a bioequivalence study, examining the use of both their new chewing gum and FDA-approved capsules, which both contain dronabinol, in the next few months. Later, the company will be showing their evidence that the use of this dronabinol gum could be used as an alternative to the dronabinol that is orally ingested to soothe chemotherapy patients.

The CEO of AXIM, John Huemoeller II, commented that the use of the chewing gum to deliver the substance makes it easier to

“enter the body through the oral mucosa, bypassing the liver and allowing for greater bioavailability.” He added that, in the upcoming studies, the company’s goal is to “show the bioequivalence of our dronabinol gum to already FDA-approved synthetic THC products so that we can offer it to chemotherapy patients.”

Market Exclusive first broke news of this development, and we will be sure to keep you updated with more information once available.

Mike Roet

Michael is a freelance writer with several years of experience in writing of all kinds. From the uber-technical to the more relaxed, he is well-versed in a variety of styles. Lately, his work has been primarily focused on the CBD industry—a market with which he has a particular background and interest. Michael has an extensive interest and experience in legal research for the CBD market, and he has a knack for well-researched pieces and guides for the growing CBD and medicinal cannabis community.


Recent Posts

  • Top Brands

Kanibi CBD: Full-Spectrum CBD Products for Healing the Body

Kanibi CBD is a company that creates several different products that contain doses of CBD…

15 hours ago
  • Food & Drinks

G&Juice Releases an All-New Line of CBD-Infused Sparkling Beverages

Up and coming beverage manufacturing firm G&Juice has just added a number of new products…

2 days ago
  • Tinctures & Drops

Peak Zen CBD: New Organic Hemp CBD-Infused Tincture Launches

Peak Zen CBD is a tincture that offers CBD to consumers to improve their health…

4 days ago
  • Announcements

New Elixinol CBD Plant-Based Sports Gel Launches with Arnica, Capsaicin and Camphor

Elixinol, a global manufacturer of CBD products, has just released a broad-spectrum CBD hemp extract…

6 days ago
  • Top Brands

Physicians Grade CBD: New Advanced Cannabidiol Formulations Release

Physicians Grade is a company that produces CBD formulas to help consumers gain the benefits…

7 days ago
  • CBD News

Gaia Herbs Launches Condition-Specific Hemp & Herbs Calm Formulas and Digestive Products

The Hemp & Herbs new line from Gaia Herbs (Brevard, NC) has just been unveiled.…

1 week ago